Team:Hong Kong HKUST/Project/module3

From 2013.igem.org

(Difference between revisions)
Line 209: Line 209:
}
}
.nine, .row .nine {
.nine, .row .nine {
-
width: 75%;
+
width: 100%;
}
}
[class*="column"] + [class*="column"]:last-child {
[class*="column"] + [class*="column"]:last-child {
Line 309: Line 309:
<div class="twelve columns">
<div class="twelve columns">
-
<h2 class="centered">Fatty Acid Quantification and Cell Viability</h2><br>
+
<h2 class="centered">Protein Trafficking</h2><br>
-
<h3 class="centered">Targeting ACE enzyme into mitochondria by Mitochondrial Leader Sequence (MLS)</h3>
+
</div>
</div>
</div>
</div>
<div class="row">
<div class="row">
<div class="nine columns">
<div class="nine columns">
-
<h3>Cell Line</h3>
+
<h3>Overview</h3>
-
In our project, two mammalian cell lines were used: human hepatoma cell (HepG2 cell) and human embryonic kidney 293 cell (HEK293FT). HepG2 cell was used for characterizing inducible promoters and glyoxylate systems. For higher transfection efficiency, the characterizations of mitochondria leader sequence and constitutive promoter were conducted using HEK293FT cells.  
+
In our project, we introduced bacterial enzymes to mammalian cell to modify metabolic pathway. However, unlike bacteria, citric acid cycle in mammalian cells is compartmentalized in mitochondria. The ACE proteins should be targeted to mitochondria for their functionality. To do so, we fused ACE enzymes with Mitochondrial Leader Sequence (MLS).
<br>
<br>
</div>
</div>
Line 322: Line 321:
<div class="row">
<div class="row">
<div class="nine columns">
<div class="nine columns">
-
<h3>Cell Culture</h3>
+
<h3>Mechanism of MLS</h3>
-
HepG2 and HEK293FT cells were maintained in DMEM supplemented with 10% heat-inactivated FBS and 50ug/mL penicillin, 50ug/mL streptomycin at 37℃in a humidified atmosphere containing 5% CO2. Cells were transfected in petri dishes and multi-well plates with different construct Lipofectamine 2000 (Invitrogen; Carlsbard, CA) according to manufacturer’s protocols. Any GFP signals were observed under fluorescent microscope or under confocal microscope if necessary.
+
MLS is attached to the N-terminal of enzyme, and bind to the receptor protein on mitochondrial membrane, and diffuse to contact site where inner and outer membrane fuse, then bring the ACE enzyme into mitochondria. Afterward, it is be cleaved, leaving the enzyme in mitochondria.
</div>
</div>
</div>
</div>
<div class="row">
<div class="row">
<div class="nine columns">
<div class="nine columns">
-
<h3>Cell Viability</h3>
+
<h3>Submission of BioBricks</h3>
-
We designed to introduce an inducible system that allows tunable fatty acid uptake by sensing fatty acid concentrations. Fatty acids uptake was to be quantified to compare the activities of wild type cells and cells expressing inducible glyoxylate shunt.
+
The MLS was cloned from a commercial plasmid, pCMV/myc/mito (Invitrogen) by PCR. For the MLS BioBrick, we have submitted the MLS BioBrick in RFC 10 and RFC 25, the Freiburg format which allows protein fusion, to facilitate other team to fuse the MLS with other protein for purpose of introducing other protein into mitochondria.  
<br><br>
<br><br>
-
To facilitate expression of inducible glyoxylate shunt in human hepatoma cell line (HepG2 cell), cell viability at different sodium palmitate concentration was measured. While a high fatty acid level is known to lead apoptosis, the cell viability test ensured maintenance of a stable cell line for transfection.<br><br>
+
For characterization, MLS and green fluorescence protein was fused with constitutive mammalian CMV promoter. The promoter was cloned from pEGFP-N1 (Clonetech) in RFC10 format, since such part could not be found in partsregistry. The CMV cloned for our characterization construct was also submitted. The two construct for characterization, the CMV promoter – green fluorescent protein – polyadenylation sequence – pSB1C3 and CMV promoter – mitochondria leader sequence – green fluorescence protein – polyadenylation sequence – pSB1C3 composite parts are also submitted. <a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Click here to see our submitted parts.</a>
-
We used MTT assay to test cell viabilities in different fatty acid concentrations. The objective was to determine a range of optimal concentrations of fatty acids to be introduced into HepG2 cell and achieve more than 60% viability after 24 hours incubation and/or more than 50% in 48 hours.<br><br>
+
-
 
+
-
<h5><b>MTT assay description</b></h5>
+
-
CMTT assay measures the enzymatic activity of oxidoreductase enzymes that only show activity when the cells are alive. MTT, a tetrazolum dye, is reduced into an insoluble formazan, giving a purple color. Organic solvent such as DMSO can be used to dissolve the formazan. Absorbance at 570 is measured using a spectrophotometer to quantitatively determine the amount of formazan formation.<br><br>
+
-
In our experiment, HepG2 cells were seeded into a 96-well plate. After one day incubation gradient concentration of sodium palmitate from 0 mM to 1.0mM, and 2.0mM were added into each row. After adding the sodium palmitate, we have incubated the cells for 24 hours and 48 hours respectively. MTT reagent was added and formazan formation was observed and measured using spectrophotometer.
+
-
 
+
-
<br><br>
+
-
<h5><b>Results</h5></b>
+
-
From the MTT assay, we observed that after 24 hours of incubation with palmitic acid, around 45% of cell viability can be maintained even at 2.0mM. For 48 hours incubation, cell viability varied for different concentrations. To maintain 50% cell viability after 48 hours incubation with palmitic acid, we concluded to experiment within range from 0mM to 0.32 mM of palmitic acid. Click on the pictures beside for a detailed result on cell viability.
+
-
<br>
+
</div>
</div>
</div>
</div>
<div class="row">
<div class="row">
<div class="nine columns">
<div class="nine columns">
-
<h3>Fatty Acid Quantification</h3>
+
<h3>Characterization</h3>
-
Two fatty acid quantification methods were investigated to measure fatty acid uptake rate of constitutive and inducible glyoxylate system: 1) Gas Chromatography-Mass Spectrophotometry (GC-MS), and 2) Fatty acid quantification kit (Sigma Aldrich). While we managed to measure fatty acid amount in cell culture medium using GC-MS, fatty acid quantification kit could not be tested due to limitation of time.<br><br>  
+
In order to characterize mitochondria that it can translocate protein into mitochondria in standard BioBrick, we constructed CMV promoter – mitochondria leader sequence – green fluorescent protein – polyadenylation sequence – pSB1C3. We use pCMV/myc/mito.GFP (Invitrogen) as positive control, which include MLS with GFP reporter, and we built negative control, CMV promoter – green fluorescent protein – polyadenylation sequence – pSB1C3 for response without MLS. Characterization was conducted on HEK 293FT cell. If the result shows that GFP is localized in mitochondria while the negative control is scatter all around cell, we can conclude that MLS is targeting GFP into mitochondria in HEK 293FT Cell.
-
<h5><b>Fatty Acid Treatment</b></h5>
+
<br><br>
-
In measuring fatty acid, fatty acid solution was mixed with ethanol and chloroform. After acidifying by HCl and refluxing in water bath for 30 min, the organic layer containing fatty acid was collected and extracted by diethyl ether and petroleum ether solution. Again the organic layer was sucked out to be dried before NaOH was added. Then after derivatisation by BF3 and bromotetradecane, the organic layer was collected into GC-MS vial for analysis.
+
Since we could not find a constitutive promoter BioBrick allow expression in mammalian cell, we amplified pCMV from pEGFP-N1 (Clonetech). To characterize this CMV promoter, we used CMV promoter – green fluorescent protein – polyadenylation sequence construct with pEGFP-N1 as positive control and GFP-PolyA in pSB1C3 as negative control. If the result shows that GFP is expressed and scatter around in cell, while negative control shows no GFP signal in cell, we can conclude that CMV is functioning.
 +
<br><br>  
 +
<h5><b>Characterization for MLS</b></h5>
 +
<p id="construct">Promoter CMV mammalian promoter to allow expressing the construct in mammalian cell.<br>Forward primer:<br><center>
 +
[TTCGCTAAGGATGATTTCTGGAATTCGCGGCCGCTTCTAGAGCTGTGGATAACCGTATTACCGCCATGC]</center><br>
 +
Reverse primer:<br><center>[CCTTGCCCTTTTTTGCCGGACTGCAGCGGCCGCTACTAGTAGATCTGACGGTTCACTAAACCAGCTCTGC]</center><br>These primers were used to amplify CMV from pEGFP-N1 (Clonetech) in RFC 10 format.  Since not enough length is kept after the transcription start site, future user may need to put spacer between the CMV promoter and the part need to be transcribed.
<br><br>
<br><br>
 +
Mitochondria Leader Sequence MLS was cloned from pCMV/myc/mito (Invitrogen) using forward primer: [GATCATGAATTCGCGGCCGCTTCTAGATGGCCGGCATGTCCGTCCTGACGCCGC] and reverse primer: [GATCATCTGCAGCGGCCGCTACTAGTATTAACCGGTCAACGAATGGATCTTGGCGCG]. The MLS was cloned with RFC 25 Freiburg standard prefix and suffix to allow doing fusion protein with MLS, to allow trafficking of reporter into mitochondria.
<h5><b>GC-MS</b></h5>
<h5><b>GC-MS</b></h5>
GC-MS is a very useful tool to quantify volatile compounds effectively. For our experiment, we conducted calibration test using known concentrations of fatty acids. However, it was difficult to reach a conclusion due to lack of internal standards and uncertain amount of sample loss for<br>
GC-MS is a very useful tool to quantify volatile compounds effectively. For our experiment, we conducted calibration test using known concentrations of fatty acids. However, it was difficult to reach a conclusion due to lack of internal standards and uncertain amount of sample loss for<br>

Revision as of 15:00, 21 September 2013

Protein Trafficking


Overview

In our project, we introduced bacterial enzymes to mammalian cell to modify metabolic pathway. However, unlike bacteria, citric acid cycle in mammalian cells is compartmentalized in mitochondria. The ACE proteins should be targeted to mitochondria for their functionality. To do so, we fused ACE enzymes with Mitochondrial Leader Sequence (MLS).

Mechanism of MLS

MLS is attached to the N-terminal of enzyme, and bind to the receptor protein on mitochondrial membrane, and diffuse to contact site where inner and outer membrane fuse, then bring the ACE enzyme into mitochondria. Afterward, it is be cleaved, leaving the enzyme in mitochondria.

Submission of BioBricks

The MLS was cloned from a commercial plasmid, pCMV/myc/mito (Invitrogen) by PCR. For the MLS BioBrick, we have submitted the MLS BioBrick in RFC 10 and RFC 25, the Freiburg format which allows protein fusion, to facilitate other team to fuse the MLS with other protein for purpose of introducing other protein into mitochondria.

For characterization, MLS and green fluorescence protein was fused with constitutive mammalian CMV promoter. The promoter was cloned from pEGFP-N1 (Clonetech) in RFC10 format, since such part could not be found in partsregistry. The CMV cloned for our characterization construct was also submitted. The two construct for characterization, the CMV promoter – green fluorescent protein – polyadenylation sequence – pSB1C3 and CMV promoter – mitochondria leader sequence – green fluorescence protein – polyadenylation sequence – pSB1C3 composite parts are also submitted. Click here to see our submitted parts.

Characterization

In order to characterize mitochondria that it can translocate protein into mitochondria in standard BioBrick, we constructed CMV promoter – mitochondria leader sequence – green fluorescent protein – polyadenylation sequence – pSB1C3. We use pCMV/myc/mito.GFP (Invitrogen) as positive control, which include MLS with GFP reporter, and we built negative control, CMV promoter – green fluorescent protein – polyadenylation sequence – pSB1C3 for response without MLS. Characterization was conducted on HEK 293FT cell. If the result shows that GFP is localized in mitochondria while the negative control is scatter all around cell, we can conclude that MLS is targeting GFP into mitochondria in HEK 293FT Cell.

Since we could not find a constitutive promoter BioBrick allow expression in mammalian cell, we amplified pCMV from pEGFP-N1 (Clonetech). To characterize this CMV promoter, we used CMV promoter – green fluorescent protein – polyadenylation sequence construct with pEGFP-N1 as positive control and GFP-PolyA in pSB1C3 as negative control. If the result shows that GFP is expressed and scatter around in cell, while negative control shows no GFP signal in cell, we can conclude that CMV is functioning.

Characterization for MLS

Promoter CMV mammalian promoter to allow expressing the construct in mammalian cell.
Forward primer:

[TTCGCTAAGGATGATTTCTGGAATTCGCGGCCGCTTCTAGAGCTGTGGATAACCGTATTACCGCCATGC]

Reverse primer:
[CCTTGCCCTTTTTTGCCGGACTGCAGCGGCCGCTACTAGTAGATCTGACGGTTCACTAAACCAGCTCTGC]

These primers were used to amplify CMV from pEGFP-N1 (Clonetech) in RFC 10 format. Since not enough length is kept after the transcription start site, future user may need to put spacer between the CMV promoter and the part need to be transcribed.

Mitochondria Leader Sequence MLS was cloned from pCMV/myc/mito (Invitrogen) using forward primer: [GATCATGAATTCGCGGCCGCTTCTAGATGGCCGGCATGTCCGTCCTGACGCCGC] and reverse primer: [GATCATCTGCAGCGGCCGCTACTAGTATTAACCGGTCAACGAATGGATCTTGGCGCG]. The MLS was cloned with RFC 25 Freiburg standard prefix and suffix to allow doing fusion protein with MLS, to allow trafficking of reporter into mitochondria.
GC-MS
GC-MS is a very useful tool to quantify volatile compounds effectively. For our experiment, we conducted calibration test using known concentrations of fatty acids. However, it was difficult to reach a conclusion due to lack of internal standards and uncertain amount of sample loss for